Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes

Molecular Medicine

Volumn 4, Issue 2, 1998, Pages 72-86

  Schroeder Jr , Harry W ^a,b,c   Zhu, Zeng Bian ^a,b   March, Ruth E ^f   Campbell, R Duncan ^f   Berney, Seth Mark ^a,b   Nedospasov, Sergei A ^g,h   Turetskaya, Regina L ^g,h   Atkinson, T Prescott ^a,d   Go, Rodney C P ^e   Cooper, Max D ^a,b,c,d,e   Volanakis, John E ^a,b  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g NATIONAL CANCER INSTITUTE   (United States)

^h ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIGENE FAMILY; PEDIGREE; PRIORITY JOURNAL;

EID: 7144227286     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401731     Document Type: Article

References (75)

1. Burrows PD, Cooper MD. (1997) IgA deficiency. Adv. Immunol. 65: 245-276.
2. Rosen FS, Wedgwood RJ, Eibl MM, Fischer A, Aiuti F, Notarangelo L, Kishimoto T, Resnick IB, Hammarstrom L, Seger R, Chapel H, Thompson RA, Cooper MD, Geha RS, Good RA, Waldmann TA. (1997) Primary Immunodeficiency diseases: Report of a WHO scientific group. Clin. Exp. Immunol. 109: S1-S28.
3. Flori NM, Llambi JM, Boren TE, Borja SR, Casariego GF. (1997) Primary immunodeficiency syndrome in Spain: First report of the National Registry in children and adults. J. Clin. Immunol. 17: 333-339.
4. Cooper MD, Lawton AR. (1972) Circulating B-cells in patients with immunodeficiency. Am. J. Pathol. 69: 513-528.
5. 2-IgA deficiency. N. Engl. J. Med. 304: 1476-1477.
6. 4. Clin. Exp. Immunol. 100: 47-53.
7. Cunningham Rundles C. (1990) Genetic aspects of immunoglobulin A deficiency. Adv. Hum. Genet. 19: 235-266.
8. Buckley RH. (1975) Clinical and immunologic features of selective IgA deficiency. Birth Defects 11: 134-142.
9. Lawton AR, Royal SA, Self KS, Cooper MD. (1972) IgA determinants on B lymphocytes in patients with deficiency of circulating IgA. J. Lab. Clin. Med. 80: 26.
10. Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H, Yoshimura K, Ohkubo Y, Yamaguchi H. (1986) Selective IgA deficiency in Japanese blood donors: Frequency and statistical analysis. Vox Sang. 50: 81-86.
11. Melamed I, Kark JD, Zakuth V, Margalil G, Spirer Z. (1987) Serum immunoglobulin A levels and ethnicity in an Israeli population sample. Clin. Immunol. Immunopathol. 42: 259-264.
12. Oen K, Petty RE, Schroeder ML. (1982) Immunoglobulin A deficiency: Genetic studies. Tissue Antigens 19: 174-182.
13. Grundbacher FJ. (1972) Genetic aspects of selective immunoglobulin A deficiency. J. Med. Genet. 9: 71.
14. Wollheim FA, Williams RC Jr. (1965) Immunoglobulin studies in six kindreds of patients with adult hypogammaglobulinemia. J. Lab. Clin. Med. 66: 433-445.
15. Schaffer FM, Palermos J, Zhu Z-B, Barger BO, Cooper MD, Volanakis JE. (1989) Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc. Natl. Acad. Sci. U.S.A. 86: 8015-8019.
16. Volanakis JE, Zhu Z-B, Schaffer FM, Macon KJ, Palermos J, Barger BO, Go R, Campbell RD, Schroeder HW Jr, Cooper MD. (1992) Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J. Clin. Invest. 89: 914-1922.
17. Wilton AN, Cubain TJ, Dawkins RL. (1985) Family studies of IgA deficiency. Immunogenetics 21: 333-342.
18. Olerup O, Smith CI, Hammarstrom L. (1990) Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 347: 289-290.
19. Ashman RF, Schaffer FM, Kemp JD, Yokoyama WM, Zhu Z-B, Cooper MD, Volanakis JE. (1992) Genetic and immunologic analysis of a family containing five patients with common variable immunodeficiency or selective IgA deficiency. J. Clin. Immunol. 12: 406-412.
20. Cunningham Rundles C, Fotino M, Rosina O, Peter JB. (1991) Selective IgA deficiency, IgG subclass deficiency, and the major histocompatibility complex. Clin. Immunol. Immunopathol. 61: S61-S69.
21. Howe HS, So AKL, Farrant J, Webster ADB. (1991) Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Clin. Exp. Immunol. 83: 387-390.
22. Bucin D, Truedsson L, Hammarstrom L, Smith CI, Sjoholm AG. (1991) C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: Association with C4A null haplotypes. Exp. Clin. Immunogenet, 8: 233-241.
23. Olerup O, Smith CIE, Bjorkander J, Hammarstrom L. (1992) Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc. Natl. Acad. Sci. U.S.A. 89: 10653-10657.
24. Campbell RD, Trowsdale J. (1997) A map of the human major histocompatibility complex. Immunol. Today 18: Centerfold.
25. Johnson ML, Keeton LG, Zhu Z-B, Volanakis JE, Cooper MD, Schroeder HW Jr. (1997) Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin. Exp. Immunol. 108: 477-483.
26. Sim E, Cross SJ. (1986) Phenotyping of human complement component C4, a class-III HLA antigen. Biochem. J. 239: 763-767.
27. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. (1993) Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16: 180-186.
28. March RE, Hsieh S-L, Khanna A, Cross SJ, Campbell RD. Application of 10 novel microsatellites mapped in the MHC class III region to the study of susceptibility loci to type I diabetes. In: HLA 1996: Proceedings of the 12th International Histocompatibility Workshop and Conference: EDK. In press.
29. D'Alfonso S, Richiardi PM. (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150-154.
30. Monos DS, Kamoun M, Udalova IA, Csanky E, Cizman B, Turetskaya RL, Smirnova JB, Zharkov VG, Gasser D, Zmijewski CM, Spielman RS, Nedospasov SA. (1995) Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus: Linkage disequilibrium of TNFαβ microsatellite alleles with HLA haplotypes. Hum. Immunol. 44: 70-79.
31. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94: 3195-3199.
32. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 87: 1233-1237.
33. Kruskall MS, Marcus-Bagley D, Awdeh Z, Eisenbarth GS, Brink SJ, Katz AJ, Hauser SL, Ahmed AR, Bing DH, Yunis EJ, Schur PH, Alper CA. (1993) Many individuals with the MHC conserved extended [HLA-B8, SC01, DR3] haplotype have immunoglobulin deficiencies. Clin. Res. 41: 277A.
34. Cudworth AG, Wolf E, Gorsuch AN, Festenstein H. (1979) A new look at HLA genetics with particular reference to type-1 diabetes. Lancet 2: 389-391.
35. Miller AP, Rich S, Barbosa J. (1981) Insulin dependent diabetic families: Sex ratio and HLA haplotype segregation. Lancet 1: 388-388.
36. Serjeantson S. (1980) Distorted HLA segregation or biased ascertainment? Lancet 1: 40-41.
37. Vadheim CM, Rotter JI, Maclaren NK, Riley WJ, Anderson CE. (1986) Preferential transmission of diabetic alleles within the HLA gene complex. N. Engl. J. Med. 315: 1314-1318.
38. Awdeh ZL, Raum D, Yunis EJ, Alper CA. (1983) Extended HLA/complement allele haplotypes: Evidence for T/t-like complex in man. Proc. Natl. Acad. Sci. U.S.A. 80: 259-263.
39. Weitkamp LR. (1979) HLA segregation ratios. Lancet 2: 745-745.
40. Hansen HE, Gurtler H. (1980) Distorted HLA segregation or biased ascertainment? Lancet 1: 41-41.
41. Klitz W, Lo SK, Neugebauer M, Baur MP, Albert ED, Thomson G. (1987) A comprehensive search for segregation distortion in HLA. Hum. Immunol. 18: 163-180.
42. Conley ME, Cooper MD. (1981) Immature IgA B cells in IgA-deficient patients. N. Engl. J. Med. 305: 495-497.
43. Eibl M, Griscelli C, Seligmann M, Aiuti F, Kishimoto T, Matsmoto S, Hanson LA, Hitzig WH, Thompson RA, Cooper MD, Good RA, Rosen FS, Waldmann TA, Wedgwood RJ. (1988) Primary immunodeficiency diseases. Report of a WHO international workshop. Immunodeficiency Rev. 1: 173-205.
44. Vukmanovic S, Vuckovic S, Stosic-Grujicic S, Ramic Z, Abinun M. (1992) An unusual T-cell surface phenotype in vivo correlates with the failure to proliferate and produce IL-2 in vitro in a patient with common variable immunodeficiency. Clin. Immunol. Immunopathol. 65: 261-270.
45. Vorechovsky I, Zetterquist H, Paganelli R, Koskinen S, Webster ADB, Björkander J, Smith CI, Hammarstrom L. (1995) Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin. Immunol. Immunopathol. 77: 185-192.
46. Clerget-Darpous F, Bonaiti-Pellie C, Hochez J. (1986) Effects of misspecifying genetic parameters in lod score analysis. Biometrics 42: 393-399.
47. Abraham LJ, Leelayuwat C, Grimsley G, Degli-Esposti MA, Mann A, Zhang WJ, Christiansen FT, Dawkins RL. (1992) Sequence differences between HLA-B and TNF distinguish different MHC ancestral haplotypes. Tissue Antigens 39: 117-121.
48. Greenberg DA, Doneshka P. (1996) Partitioned association-linkage test: Distinguishing "necessary" from "susceptibility" loci. Genet. Epidemiol. 13: 243-252.
49. Cucca F, Zhu Z-B, Khanna A, Cossu F, Congia M, Badiali M, Cao A, Arnone M, Piras P, Campbell D, Cooper MD, Volanakis JE, Powis SH. (1998) Evaluation of immunoglobulin A deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin. Exp. Immunol. 111: 76-80.
50. Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L, La Nasa G, Mulargia M, Pirastu M, Cao A, de Virgiliis S. (1992) A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: Further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 39: 78-83.
51. Liu YJ, Banchereau J. (1996) Mutant mice without B lymphocyte follicles. J. Exp. Med. 184: 1207-1211.
52. Ware CF, VanArsdale TL, Crowe PD, Browning JL. (1995) The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198: 175-218.
53. Watanabe Y, Jacob CO. (1991) Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. J. Immunol. 146: 899-905.
54. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72: 847-856.
55. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WF, Goodwin RG, Smith CA. (1994) A lymphotoxin-beta-specific receptor. Science 264: 707-710.
56. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD. (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
57. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. (1996) Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184: 1999-2006.
58. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. (1997) Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity 6: 491-500.
59. Banks TA, Rouse BT, Kerley MK, Blair PJ, Godfrey VL, Kuklin NA, Bouley DM, Thomas J, Kanangat S, Mucenski ML. (1995) Lymphotoxin-a-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155: 1685-1693.
60. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL, Tarakhovsky A, Rajewsky K, Nedospasov SA, Pfeffer K. (1997) Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94: 9302-9307.
61. Fu YX, Molina H, Matsumoto M, Huang G, Min J, Chaplin DD. (1997) Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185: 2111-2120.
62. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. (1996) Immune and inflammatory responses in TNF-α-deficient mice: A crtical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the immune response. J. Exp. Med. 184: 1397-1411.
63. Freund YR, Sgarlato G, Jacob CO, Suzuki Y, Remington JS. (1992) Polymorphisms in the tumor necrosis factor α (TNF-α) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-αmRNA in infected brain tissue. J. Exp. Med. 175: 683-688.
64. Muller KM, Lisby S, Arrighi JF, Grau GE, Saurat JH, Hauser C. (1994) H-2D haplotype-linked expression and involvement of TNF-α in Th2 cell-mediated tissue inflammation. J. Immunol. 153: 316-324.
65. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. (1993) An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 177: 557-560.
66. Abraham LJ, Du DC, Zahedi K, Dawkins RL, Whitehead AS. (1991) Haplotypic polymorphisms of the TNFB gene. Immunogenetics 33: 50-53.
67. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. (1996) Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles: Relevance for inflammatory bowel disease. Scan. J. Immunol. 43: 456-463.
68. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J. Exp. Med. 173: 209-219.
69. Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenharth GS, Brink SJ, Hauser SL. (1996) Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum. Immunol. 50: 11-21.
70. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. (1994) Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510.
71. Jongeneel CV, Beutler B. (1995) Genetic polymorphism in the human TNF region: Correlation or causation? J. Inftam. 46: iii-ivi.
72. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. (1995) Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. J. Inflam. 46: 32-41.
73. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA. (1995) -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflam. 46: 42-50.
74. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94: 8093-8098.
75. Amiot F, Boussadia O, Cases S, Fitting C, Lebastard M, Cavaillon JM, Milon G, Dautry F. (1997) Mice heterozygous for a deletion of the tumor necrosis factor-α and lymphotoxin-α genes: Biological importance of a nonlinear response of tumor necrosis factor-α to gene dosage. Eur. J. Immunol. 27: 1035-1042.